73 related articles for article (PubMed ID: 16783779)
21. Frequency and outcome of cervical cancer prevention failures in the United States.
Raab SS; Grzybicki DM; Zarbo RJ; Jensen C; Geyer SJ; Janosky JE; Meier FA; Vrbin CM; Carter G; Geisinger KR
Am J Clin Pathol; 2007 Nov; 128(5):817-24. PubMed ID: 17951205
[TBL] [Abstract][Full Text] [Related]
22. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
23. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
24. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results.
Diaz-Montes TP; Farinola MA; Zahurak ML; Bristow RE; Rosenthal DL
Gynecol Oncol; 2007 Feb; 104(2):366-71. PubMed ID: 17049972
[TBL] [Abstract][Full Text] [Related]
25. Pap smear screening in an urban STD clinic. Yield of screening and predictors of abnormalities.
Shlay JC; McGill WL; Masloboeva HA; Douglas JM
Sex Transm Dis; 1998 Oct; 25(9):468-75. PubMed ID: 9800258
[TBL] [Abstract][Full Text] [Related]
26. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
[TBL] [Abstract][Full Text] [Related]
27. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of epithelial cell abnormalities of uterine cervix in a cervical cancer screening programme: implications for resource limited settings.
Gupta S; Sodhani P; Halder K; Chachra KL; Sardana S; Singh V; Sehgal A
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):238-42. PubMed ID: 16920248
[TBL] [Abstract][Full Text] [Related]
29. HPV detection rate in discordant Pap tests between cytotechnologists and pathologists.
Chhieng DC; Bakdounes K; Connolly M; Gallaspy S; Roberson J; Eltoum I
Diagn Cytopathol; 2009 May; 37(5):320-3. PubMed ID: 19191288
[TBL] [Abstract][Full Text] [Related]
30. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
31. Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women: lessons learned from human Papillomavirus DNA testing.
Johnston EI; Logani S
Cancer; 2007 Jun; 111(3):160-5. PubMed ID: 17506090
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of the SurePath liquid-based Pap test in automated screening and in detection of HSIL.
Cengel KA; Day SJ; Davis-Devine S; Adams CL; Madison-Henness D; Hartman ME; Freund GG
Diagn Cytopathol; 2003 Nov; 29(5):250-5. PubMed ID: 14595790
[TBL] [Abstract][Full Text] [Related]
33. Cytologic correlates of papillary immature metaplasia (immature condyloma) of the cervix.
Mosher RE; Lee KR; Trivijitsilp P; Crum CP
Diagn Cytopathol; 1998 Jun; 18(6):416-21. PubMed ID: 9626513
[TBL] [Abstract][Full Text] [Related]
34. Reproducibility of subclassification of squamous intraepithelial lesions: conventional versus ThinPrep paps.
Adams KC; Absher KJ; Brill YM; Witzke DB; Davey DD
J Low Genit Tract Dis; 2003 Jul; 7(3):203-8. PubMed ID: 17051069
[TBL] [Abstract][Full Text] [Related]
35. Atypical endometrial cells and atypical glandular cells favor endometrial origin in Papanicolaou cervicovaginal tests: Correlation with histologic follow-up and abnormal clinical presentations.
Chen L; Booth CN; Shorie JA; Brainard JA; Zarka MA
Cytojournal; 2014; 11():29. PubMed ID: 25506385
[TBL] [Abstract][Full Text] [Related]
36. Pap test discrepancies and follow-up histology.
Stelow EB; Skeate R; Wahi MM; Kjeldahl K; McKeon D; Larkin S; Woronzoff K; Pambuccian SE
Diagn Cytopathol; 2003 Aug; 29(2):111-5. PubMed ID: 12889052
[TBL] [Abstract][Full Text] [Related]
37. Cytologic parameters predicting neoplasia in Papanicolaou smears with atypical glandular cells and histologic follow-up: a single-institution experience.
Reynolds JP; Salih ZT; Smith AL; Dairi M; Kigen OJ; Nassar A
J Am Soc Cytopathol; 2018; 7(1):7-15. PubMed ID: 31043252
[TBL] [Abstract][Full Text] [Related]
38. Improving Papanicolaou test quality and reducing medical errors by using Toyota production system methods.
Raab SS; Andrew-Jaja C; Condel JL; Dabbs DJ
Am J Obstet Gynecol; 2006 Jan; 194(1):57-64. PubMed ID: 16389010
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of a histologic prognostic test and a cytologic prognostic test in cancer of the cervix uteri].
Prade M; Maillet M; Wolff JP
Arch Anat Pathol (Paris); 1967; 15():Suppl:87-90. PubMed ID: 5599732
[No Abstract] [Full Text] [Related]
40. Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study.
Stein MD; Fregnani JH; Scapulatempo-Neto C; Longatto-Filho A
Diagn Pathol; 2015 Jan; 10():1. PubMed ID: 25591792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
